(mg) Prazepam;
CSB 2.19(4) (4)Paragraph (hg) of s. 161.20 (2), Stats., is created to read:
(hg) Midazolam;
CSB 2.19(5) (5)Paragraph (mm) of s. 161.20 (2), Stats., is created to read:
(mm) Quazepam;
CSB 2.19(6) (6)Paragraph (km) of s. 161.18 (3), Stats., is created to read:
(km) Tiletamine and Zolazepam or any salt thereof;
CSB 2.19(7) (7)Paragraph (a) of s. 161.16 (3), Stats., is renumbered to read:
(am) Alphaprodine;
CSB 2.19(8) (8)Paragraph (a) of s. 161.16 (3), Stats., is created to read:
(a) Alfentanil;
CSB 2.19(9) (9)Paragraph (rg) of s. 161.14 (2), Stats., is created to read:
(rg) MPPP 1-methyl-4-phenyl-4-propionoxypiperidine);
CSB 2.19(10) (10)Paragraph (vg) of s. 161.14 (2), Stats., is created to read:
(vg) (PEPAP) 1-(2-phenethyl)-4-phenyl-4-acetoxypiperidine;
CSB 2.19(11) (11)Paragraph (b) of s. 161.16 (10), Stats., is created to read:
(b) Nabilone (another name for nabilone: (+)-trans-3- (1,1-dimethylheptyl)-6, 6a, 7, 8, 10, 10a-hexahydro-1- hydroxy-6, 6-dimethyl-9H-dibenzo [b,d] pyran-9-one).
CSB 2.19(12) (12)Subsection (2) of s. 161.14, Stats., is amended to read:
(2) Opiates. Unless specifically excepted under federal regulations or unless listed in another schedule, any of the following opiates, or their isomers, esters, ethers, salts, salts of isomers, esters of ethers, if isomers, esters, ethers, salts or salts of isomers exist within the specified chemical designation (for purposes of par. (tg) only, the term isomer includes the optical and geometric isomers):
CSB 2.19(13) (13)Paragraph (a) of s. 161.14 (2), Stats., is renumbered to read:
(ag) Acetylmethadol;
CSB 2.19(14) (14)Paragraph (a) of s. 161.14 (2), Stats., is created to read:
(a) Acetyl-alpha-methylfentanyl (N-(1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);
CSB 2.19(15) (15)Paragraph (cg) of s. 161.14 (2), Stats., is created to read:
(cg) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
CSB 2.19(16) (16)Paragraph (dg) of s. 161.14 (2), Stats., is created to read:
(dg) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl) -4-piperidinyl]-N-phenylpropanamide);
CSB 2.19(17) (17) Paragraph (rj) of s. 161.14 (2), Stats., is created to read:
(rj) 3-methylthiofentanyl (N-[3-methyl-1-(2-thienyl) ethyl-4-piperidinyl]-N-phenylpropanamide);
CSB 2.19(18) (18)Paragraph (tg) of s. 161.14 (2), Stats., is created to read:
(tg) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1- (2-phenethyl)-4-piperidinyl]propanamide);
CSB 2.19(19) (19)Paragraph (xm) of s. 161.14 (2), Stats., is created to read:
(xm) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]propanamide);
CSB 2.19 History History: Cr. Register, February, 1988, No. 386, eff. 3-1-88.
CSB 2.20 CSB 2.20 Addition of beta-hydroxy-3-methylfentanyl to schedule I. Paragraph (er) of s. 161.14 (2), Stats., is created to read:
(er) Beta-hydroxy-3-methylfentanyl.
CSB 2.20 History History: Cr. Register, July, 1989, No. 403, eff. 8-1-89.
CSB 2.21 CSB 2.21 Additions, deletions, corrections, transfers, and amendments to drug schedules.
CSB 2.21(1) (1)Subsection (1) of s. 161.14, Stats., is amended to read:
(1) Included substances. Unless specifically excepted by state or federal law or regulation or more specifically included in another schedule, the following controlled substances are listed in schedule I.
CSB 2.21(2) (2)Paragraph (a) of s. 161.14 (2), Stats., is amended to read:
(a) Acetyl-alpha-methylfentany (N-[1-(1-methyl-2-phenylethyl)-4-piperidinyl]-N-phenylacetamide);
CSB 2.21(3) (3)Paragraph (er) of s. 161.14 (2), Stats., is amended to read:
(er) Beta-hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2- phenylethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide);
CSB 2.21(4) (4)Paragraph (rg) of s. 161.14 (2), Stats., is amended to read:
(rg) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine);
CSB 2.21(5) (5)Paragraph (qs) of s. 161.14 (2), Stats., is amended to read:
(qs) 3-methylfentanyl (N-[3-methyl-1-(2-phenylethyl)-4-
piperidinyl]-N-phenylpropanamide);
CSB 2.21(6) (6)Paragraph (tg) of s. 161.14 (2), Stats., is amended to read:
(tg) Para-fluorofentanyl (N-[1-(2-phenylethyl)-4-piperidinyl]-N-(4-fluorophenyl)propanamide);
CSB 2.21(7) (7)Paragraph (vg) of s. 161.14 (2), Stats., is amended to read:
(vg) PEPAP (1-(2-phenylethyl)-4-phenyl-4-acetoxypiperidine);
CSB 2.21(8) (8)Paragraph (xm) of s. 161.14 (2), Stats., is amended to read:
(xm) Thiofentanyl (N-[1-(2-thienyl)ethyl-4-piperidinyl]-N-
phenylpropanamide);
CSB 2.21(9) (9)Paragraph (cd) of s. 161.14 (2), Stats., is created to read:
(cd) Alpha-methylfentanyl (N-[1-(1-methyl-2-phenylethyl)-4-piperidinyl]-N-phenylpropanamide);
CSB 2.21(10) (10)Paragraph (e) of s. 161.14 (3), Stats., is amended to read:
(e) Codeine-N-oxide;
CSB 2.21(11) (11)Paragraph (j) of s. 161.14 (3), Stats., is amended to read:
(j) Etorphine, except its hydrochloride salts;
CSB 2.21(12) (12)Paragraph (s) of s. 161.14 (3), Stats., is amended to read:
(s) Morphine-N-oxide;
CSB 2.21(13) (13)Paragraph (a) of s. 161.14 (4), Stats., is amended to read:
(a) 3,4-methylenedioxyamphetamine, commonly known as "MDA";
CSB 2.21(14) (14)Paragraph (b) of s. 161.14 (4), Stats., is amended to read:
(b) 5-methoxy-3,4-methylenedioxyamphetamine;
CSB 2.21(15) (15)Paragraph (c) of s. 161.14 (4), Stats., is amended to read:
(c) 3,4,5-trimethoxyamphetamine;
CSB 2.21(16) (16)Paragraph (ag) of s. 161.14 (4), Stats., is created to read:
(ag) 3,4-methylenedioxyethylamphetamine, commonly known as "MDE";
CSB 2.21(17) (17)Paragraph (ar) of s. 161.14 (4), Stats., is created to read:
(ar) N-hydroxy-3,4-methylenedioxyamphetamine;
CSB 2.21(18) (18)Paragraph (u) of s. 161.14 (4), Stats., is amended to read:
(u) 1-[1-(2-thienyl)cyclohexyl]piperidine, which is the thiophene analog of phencyclidine;
CSB 2.21(19) (19)Paragraph (ud) of s. 161.14 (4), Stats., is created to read:
(ud) 1-[1-(2-thienyl)cyclohexyl]pyrrolidine, which is the thiophene pyrrolidine analog of phencyclidine;
CSB 2.21(20) (20)Paragraph (ur) of s. 161.14 (4), Stats., is amended to read:
(ur) 1-(1-phenylcyclohexyl)pyrrolidine, which is the pyrrolidine analog of phencyclidine;
CSB 2.21(21) (21)Paragraph (d) of s. 161.14 (7), Stats., is created to read:
(d) 4-methylaminorex, including its salts and salts of isomers;
CSB 2.21(22) (22)Paragraph (e) of s. 161.14 (7), Stats., is created to read:
(e) N,N-dimethylamphetamine, including its salts and salts of isomers.
CSB 2.21(23) (23)Paragraph (L) of s. 161.14 (7), Stats., is created to read:
(L) methcathinone, including its salts and salts of isomers.
CSB 2.21(24) (24)Subdivision 4m of s. 161.16 (2) (a), Stats., is created to read:
4m. Dihydrocodeine;
CSB 2.21(25) (25)Paragraph (d) of s. 161.16 (3), Stats., is repealed.
CSB 2.21(26) (26)Paragraph (am) of s. 161.16 (7), Stats., is created to read: 
(am) Glutethimide;
Loading...
Loading...
Published under authority of s. 35.93, Stats. Updated on the first day of each month. Entire code is alwaycurrent. The date shown on each chapter is the date the chapter was last published.